ID

15685

Description

Nerventra Study (Eudra CT 2007-003226-19) Study MS-LAQ-301: A multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study, to evaluate the safety, tolerability and efficacy of daily oral administration of laquinimod 0.6 mg in subjects with relapsing remitting multiple sclerosis (RRMS)

Mots-clés

Versions (1)
  1. 08/06/2016 08/06/2016 -
Téléchargé le

8 juin 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Nerventra Study Adverse event log

Anglais

Nerventra Study Adverse event log

1 Formulaires  
Demographic Information
Description

Demographic Information

Protocol Number
Description

Protocol Number

Type de données

text

Alias
UMLS CUI [1,1]
C0008971
UMLS CUI [1,2]
C0600091
Visit Type
Description

i.e "Screening"

Type de données

text

Alias
UMLS CUI [1]
C0545082
Date of visit
Description

Visit date

Type de données

date

Alias
UMLS CUI [1]
C1320303
Study site number
Description

Study site

Type de données

integer

Alias
UMLS CUI [1]
C2825164
Subject number:
Description

Subject number

Type de données

integer

Alias
UMLS CUI [1]
C1709561
Section blank
Description

Blank

Type de données

boolean

Alias
UMLS CUI [1]
C0750479
Ongoing adverse events
Description

Ongoing adverse events

Date of automatic update
Description

Date of automatic update

Type de données

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0205554
UMLS CUI [1,3]
C1519814
Date of manual update
Description

Date of manual update

Type de données

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0175674
UMLS CUI [1,3]
C1519814
Adverse event
Description

Adverse event

Type de données

text

Alias
UMLS CUI [1]
C0877248
Visit Type
Description

Visit

Type de données

text

Alias
UMLS CUI [1]
C0545082
Adverse events log Baseline
Description

Adverse events log Baseline

Adverse event
Description

Adverse event

Type de données

text

Alias
UMLS CUI [1]
C0877248
Adverse event intermittent
Description

Adverse event intermittent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0205267
Time since dose
Description

Time since dose

Type de données

time

Alias
UMLS CUI [1]
C0946444
Time since dose unknown
Description

Time since dose

Type de données

boolean

Alias
UMLS CUI [1]
C0946444
Prior to first dose
Description

Prior to first dose

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332152
UMLS CUI [1,2]
C3469597
Date of onset
Description

Date of onset

Type de données

date

Alias
UMLS CUI [1]
C0574845
Is the Adverse Event Ongoing?
Description

Adverse Event Ongoing

Type de données

boolean

Alias
UMLS CUI [1]
C2826663
Adverse Event less than one day
Description

Adverse Event less than one day

Type de données

boolean

Alias
UMLS CUI [1]
C3843198
Severity
Description

Severity

Type de données

text

Alias
UMLS CUI [1]
C0439793
Serious (If yes, complete SAE report)
Description

Serious

Type de données

boolean

Alias
UMLS CUI [1]
C0205404
Action Taken with Study Treatment
Description

Action Taken with Study Treatment

Type de données

text

Alias
UMLS CUI [1]
C2826626
If study drug is discontinued, is this the primary AE?
Description

Primary AE

Type de données

boolean

Alias
UMLS CUI [1,1]
C0205225
UMLS CUI [1,2]
C0877248
Outcome to event
Description

Adverse Event Outcome

Type de données

text

Alias
UMLS CUI [1]
C1705586
Relation to study drug
Description

Drugs

Type de données

text

Alias
UMLS CUI [1]
C0013227
Adverse events Visit 1
Description

Adverse events Visit 1

Adverse event
Description

Adverse event

Type de données

text

Alias
UMLS CUI [1]
C0877248
Adverse event intermittent
Description

Adverse event intermittent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0205267
Time since dose
Description

Time since dose

Type de données

time

Alias
UMLS CUI [1]
C0946444
Time since dose unknown
Description

Time since dose

Type de données

boolean

Alias
UMLS CUI [1]
C0946444
Prior to first dose
Description

Prior to first dose

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332152
UMLS CUI [1,2]
C3469597
Date of onset
Description

Date of onset

Type de données

date

Alias
UMLS CUI [1]
C0574845
Is the Adverse Event Ongoing?
Description

Adverse Event Ongoing

Type de données

boolean

Alias
UMLS CUI [1]
C2826663
Adverse Event less than one day
Description

Adverse Event less than one day

Type de données

boolean

Alias
UMLS CUI [1]
C3843198
Severity
Description

Severity

Type de données

text

Alias
UMLS CUI [1]
C0439793
Serious (If yes, complete SAE report)
Description

Serious

Type de données

boolean

Alias
UMLS CUI [1]
C0205404
Action Taken with Study Treatment
Description

Action Taken with Study Treatment

Type de données

text

Alias
UMLS CUI [1]
C2826626
If study drug is discontinued, is this the primary AE?
Description

Primary AE

Type de données

boolean

Alias
UMLS CUI [1,1]
C0205225
UMLS CUI [1,2]
C0877248
Outcome to event
Description

Adverse Event Outcome

Type de données

text

Alias
UMLS CUI [1]
C1705586
Relation to study drug
Description

Drugs

Type de données

text

Alias
UMLS CUI [1]
C0013227
Retour au début de la page

Similar models

Nerventra Study Adverse event log

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Demographic Information
Protocol Number
Item
Protocol Number
text
C0008971 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Visit
Item
Visit Type
text
C0545082 (UMLS CUI [1])
Visit date
Item
Date of visit
date
C1320303 (UMLS CUI [1])
Study site
Item
Study site number
integer
C2825164 (UMLS CUI [1])
Subject number
Item
Subject number:
integer
C1709561 (UMLS CUI [1])
Blank
Item
Section blank
boolean
C0750479 (UMLS CUI [1])
Item Group
Ongoing adverse events
Date of automatic update
Item
Date of automatic update
date
C0011008 (UMLS CUI [1,1])
C0205554 (UMLS CUI [1,2])
C1519814 (UMLS CUI [1,3])
Date of manual update
Item
Date of manual update
date
C0011008 (UMLS CUI [1,1])
C0175674 (UMLS CUI [1,2])
C1519814 (UMLS CUI [1,3])
Adverse event
Item
Adverse event
text
C0877248 (UMLS CUI [1])
Visit
Item
Visit Type
text
C0545082 (UMLS CUI [1])
Item Group
Adverse events log Baseline
Adverse event
Item
Adverse event
text
C0877248 (UMLS CUI [1])
Adverse event intermittent
Item
Adverse event intermittent
boolean
C0877248 (UMLS CUI [1,1])
C0205267 (UMLS CUI [1,2])
Time since dose
Item
Time since dose
time
C0946444 (UMLS CUI [1])
Time since dose
Item
Time since dose unknown
boolean
C0946444 (UMLS CUI [1])
Prior to first dose
Item
Prior to first dose
boolean
C0332152 (UMLS CUI [1,1])
C3469597 (UMLS CUI [1,2])
Date of onset
Item
Date of onset
date
C0574845 (UMLS CUI [1])
Adverse Event Ongoing
Item
Is the Adverse Event Ongoing?
boolean
C2826663 (UMLS CUI [1])
Adverse Event less than one day
Item
Adverse Event less than one day
boolean
C3843198 (UMLS CUI [1])
Severity
Item
Severity
text
C0439793 (UMLS CUI [1])
Serious
Item
Serious (If yes, complete SAE report)
boolean
C0205404 (UMLS CUI [1])
Action Taken with Study Treatment
Item
Action Taken with Study Treatment
text
C2826626 (UMLS CUI [1])
Primary AE
Item
If study drug is discontinued, is this the primary AE?
boolean
C0205225 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Adverse Event Outcome
Item
Outcome to event
text
C1705586 (UMLS CUI [1])
Drugs
Item
Relation to study drug
text
C0013227 (UMLS CUI [1])
Item Group
Adverse events Visit 1
Adverse event
Item
Adverse event
text
C0877248 (UMLS CUI [1])
Adverse event intermittent
Item
Adverse event intermittent
boolean
C0877248 (UMLS CUI [1,1])
C0205267 (UMLS CUI [1,2])
Time since dose
Item
Time since dose
time
C0946444 (UMLS CUI [1])
Time since dose
Item
Time since dose unknown
boolean
C0946444 (UMLS CUI [1])
Prior to first dose
Item
Prior to first dose
boolean
C0332152 (UMLS CUI [1,1])
C3469597 (UMLS CUI [1,2])
Date of onset
Item
Date of onset
date
C0574845 (UMLS CUI [1])
Adverse Event Ongoing
Item
Is the Adverse Event Ongoing?
boolean
C2826663 (UMLS CUI [1])
Adverse Event less than one day
Item
Adverse Event less than one day
boolean
C3843198 (UMLS CUI [1])
Severity
Item
Severity
text
C0439793 (UMLS CUI [1])
Serious
Item
Serious (If yes, complete SAE report)
boolean
C0205404 (UMLS CUI [1])
Action Taken with Study Treatment
Item
Action Taken with Study Treatment
text
C2826626 (UMLS CUI [1])
Primary AE
Item
If study drug is discontinued, is this the primary AE?
boolean
C0205225 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Adverse Event Outcome
Item
Outcome to event
text
C1705586 (UMLS CUI [1])
Drugs
Item
Relation to study drug
text
C0013227 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial